Search Course Outline
Showing 25 course outlines from 2250 matches
701
MEDSCI 710
: Nutrition Mechanisms2020 Semester Two (1205)
The mechanisms by which food and food components can influence disease processes. Topics covered include: the interaction between genotype and nutrition, antioxidants and oxidation protection mechanisms, dietary toxicology, the process of atherosclerosis, and the influence of the intra-uterine environment on growth and disease.
No pre-requisites or restrictions
702
MEDSCI 712
: Critical Evaluation of Nutritional Therapies2024 Semester Two (1245)
The suggested roles for micronutrients, 'nutriceuticals' and functional foods in general health, exercise performance and disease are evaluated using an evidence-based approach. The roles of micronutrients as dietary supplements and the potential actions of nutriceuticals and functional foods are also critically evaluated. Regulatory and ethical issues in the use of nutritional remedies are considered, including their use as supplements in chemotherapy or other conventional therapies, or in individuals with no symptoms.
No pre-requisites or restrictions
703
MEDSCI 712
: Critical Evaluation of Nutritional Therapies2022 Semester Two (1225)
The suggested roles for micronutrients, 'nutriceuticals' and functional foods in general health, exercise performance and disease are evaluated using an evidence-based approach. The roles of micronutrients as dietary supplements and the potential actions of nutriceuticals and functional foods are also critically evaluated. Regulatory and ethical issues in the use of nutritional remedies are considered, including their use as supplements in chemotherapy or other conventional therapies, or in individuals with no symptoms.
No pre-requisites or restrictions
704
MEDSCI 712
: Critical Evaluation of Nutritional Therapies2021 Semester Two (1215)
The suggested roles for micronutrients, 'nutriceuticals' and functional foods in general health, exercise performance and disease are evaluated using an evidence-based approach. The roles of micronutrients as dietary supplements and the potential actions of nutriceuticals and functional foods are also critically evaluated. Regulatory and ethical issues in the use of nutritional remedies are considered, including their use as supplements in chemotherapy or other conventional therapies, or in individuals with no symptoms.
No pre-requisites or restrictions
705
MEDSCI 712
: Critical Evaluation of Nutritional Therapies2020 Semester Two (1205)
The suggested roles for micronutrients, 'nutriceuticals' and functional foods in general health, exercise performance and disease are evaluated using an evidence-based approach. The roles of micronutrients as dietary supplements and the potential actions of nutriceuticals and functional foods are also critically evaluated. Regulatory and ethical issues in the use of nutritional remedies are considered, including their use as supplements in chemotherapy or other conventional therapies, or in individuals with no symptoms.
No pre-requisites or restrictions
706
MEDSCI 713
: Principles of Cancer Therapy2024 Semester One (1243)
Examines the molecular and cellular processes underlying cancer treatment and the development of tumour-selective therapy; the principles of radiotherapy and chemotherapy; DNA and the basis for its interactions with anticancer drugs; recognition of DNA by proteins; exploitation of these processes by anticancer drugs, oncogenes and other regulatory gene products; signal transduction mechanisms and strategies for changing cell cycle control; cytokines and the role of host responses in cancer therapy; new approaches to cancer therapy including gene therapy and photodynamic therapy.
Prerequisite: MEDSCI 302
707
MEDSCI 713
: Principles of Cancer Therapy2023 Semester One (1233)
Examines the molecular and cellular processes underlying cancer treatment and the development of tumour-selective therapy; the principles of radiotherapy and chemotherapy; DNA and the basis for its interactions with anticancer drugs; recognition of DNA by proteins; exploitation of these processes by anticancer drugs, oncogenes and other regulatory gene products; signal transduction mechanisms and strategies for changing cell cycle control; cytokines and the role of host responses in cancer therapy; new approaches to cancer therapy including gene therapy and photodynamic therapy.
Prerequisite: MEDSCI 302
708
MEDSCI 713
: Principles of Cancer Therapy2022 Semester One (1223)
Examines the molecular and cellular processes underlying cancer treatment and the development of tumour-selective therapy; the principles of radiotherapy and chemotherapy; DNA and the basis for its interactions with anticancer drugs; recognition of DNA by proteins; exploitation of these processes by anticancer drugs, oncogenes and other regulatory gene products; signal transduction mechanisms and strategies for changing cell cycle control; cytokines and the role of host responses in cancer therapy; new approaches to cancer therapy including gene therapy and photodynamic therapy.
Prerequisite: MEDSCI 302
709
MEDSCI 713
: Principles of Cancer Therapy2021 Semester One (1213)
Examines the molecular and cellular processes underlying cancer treatment and the development of tumour-selective therapy; the principles of radiotherapy and chemotherapy; DNA and the basis for its interactions with anticancer drugs; recognition of DNA by proteins; exploitation of these processes by anticancer drugs, oncogenes and other regulatory gene products; signal transduction mechanisms and strategies for changing cell cycle control; cytokines and the role of host responses in cancer therapy; new approaches to cancer therapy including gene therapy and photodynamic therapy.
Prerequisite: MEDSCI 302
710
MEDSCI 713
: Principles of Cancer Therapy2020 Semester One (1203)
Examines the molecular and cellular processes underlying cancer treatment and the development of tumour-selective therapy; the principles of radiotherapy and chemotherapy; DNA and the basis for its interactions with anticancer drugs; recognition of DNA by proteins; exploitation of these processes by anticancer drugs, oncogenes and other regulatory gene products; signal transduction mechanisms and strategies for changing cell cycle control; cytokines and the role of host responses in cancer therapy; new approaches to cancer therapy including gene therapy and photodynamic therapy.
Prerequisite: MEDSCI 302
711
MEDSCI 714
: Advanced Cancer Biology2024 Semester One (1243)
Advanced studies of concepts related to the biology of cancer. These will include: molecular mechanisms, signal transduction pathways, genomic instability, telomeres and telomerase, anoikis, DNA damage sensing mechanisms, and hypoxia and tumour progression.
Prerequisite: MEDSCI 302
712
MEDSCI 714
: Advanced Cancer Biology2023 Semester One (1233)
Advanced studies of concepts related to the biology of cancer. These will include: molecular mechanisms, signal transduction pathways, genomic instability, telomeres and telomerase, anoikis, DNA damage sensing mechanisms, and hypoxia and tumour progression.
Prerequisite: MEDSCI 302
713
MEDSCI 714
: Advanced Cancer Biology2022 Semester One (1223)
Advanced studies of concepts related to the biology of cancer. These will include: molecular mechanisms, signal transduction pathways, genomic instability, telomeres and telomerase, anoikis, DNA damage sensing mechanisms, and hypoxia and tumour progression.
Prerequisite: MEDSCI 302
714
MEDSCI 714
: Advanced Cancer Biology2021 Semester One (1213)
Advanced studies of concepts related to the biology of cancer. These will include: molecular mechanisms, signal transduction pathways, genomic instability, telomeres and telomerase, anoikis, DNA damage sensing mechanisms, and hypoxia and tumour progression.
Prerequisite: MEDSCI 302
715
MEDSCI 714
: Advanced Cancer Biology2020 Semester One (1203)
Advanced studies of concepts related to the biology of cancer. These will include: molecular mechanisms, signal transduction pathways, genomic instability, telomeres and telomerase, anoikis, DNA damage sensing mechanisms, and hypoxia and tumour progression.
Prerequisite: MEDSCI 302
716
MEDSCI 715
: Molecular Toxicology2024 Semester One (1243)
Covers the current understanding of mechanisms implicated in toxicity of drugs and environmental chemicals plus the basis of inter-individual susceptibility. The course identifies strategies used to predict and prevent adverse reactions during drug development.
No pre-requisites or restrictions
717
MEDSCI 715
: Molecular Toxicology2023 Semester One (1233)
Covers the current understanding of mechanisms implicated in toxicity of drugs and environmental chemicals plus the basis of inter-individual susceptibility. The course identifies strategies used to predict and prevent adverse reactions during drug development.
No pre-requisites or restrictions
718
MEDSCI 715
: Molecular Toxicology2022 Semester One (1223)
Covers the current understanding of mechanisms implicated in toxicity of drugs and environmental chemicals plus the basis of inter-individual susceptibility. The course identifies strategies used to predict and prevent adverse reactions during drug development.
No pre-requisites or restrictions
719
MEDSCI 715
: Molecular Toxicology2021 Semester One (1213)
Covers the current understanding of mechanisms implicated in toxicity of drugs and environmental chemicals plus the basis of inter-individual susceptibility. The course identifies strategies used to predict and prevent adverse reactions during drug development.
No pre-requisites or restrictions
720
MEDSCI 715
: Molecular Toxicology2020 Semester One (1203)
Covers the current understanding of mechanisms implicated in toxicity of drugs and environmental chemicals plus the basis of inter-individual susceptibility. The course identifies strategies used to predict and prevent adverse reactions during drug development.
No pre-requisites or restrictions
721
MEDSCI 716
: Advanced Drug Disposition and Kinetics2024 Semester One (1243)
Advanced study of the absorption, distribution, metabolism and excretion of drugs, and the analysis of these processes. Also included are: in vivo/in vitro techniques in drug ADME studies used in drug development; drug analysis in biological matrices; and pharmaco-genomic aspects related to drug disposition.
No pre-requisites or restrictions
722
MEDSCI 716
: Advanced Drug Disposition and Kinetics2023 Semester One (1233)
Advanced study of the absorption, distribution, metabolism and excretion of drugs, and the analysis of these processes. Also included are: in vivo/in vitro techniques in drug ADME studies used in drug development; drug analysis in biological matrices; and pharmaco-genomic aspects related to drug disposition.
No pre-requisites or restrictions
723
MEDSCI 716
: Advanced Drug Disposition and Kinetics2022 Semester One (1223)
Advanced study of the absorption, distribution, metabolism and excretion of drugs, and the analysis of these processes. Also included are: in vivo/in vitro techniques in drug ADME studies used in drug development; drug analysis in biological matrices; and pharmaco-genomic aspects related to drug disposition.
No pre-requisites or restrictions
724
MEDSCI 716
: Advanced Drug Disposition and Kinetics2021 Semester One (1213)
Advanced study of the absorption, distribution, metabolism and excretion of drugs, and the analysis of these processes. Also included are: in vivo/in vitro techniques in drug ADME studies used in drug development; drug analysis in biological matrices; and pharmaco-genomic aspects related to drug disposition.
No pre-requisites or restrictions
725
MEDSCI 716
: Advanced Drug Disposition and Kinetics2020 Semester One (1203)
Advanced study of the absorption, distribution, metabolism and excretion of drugs, and the analysis of these processes. Also included are: in vivo/in vitro techniques in drug ADME studies used in drug development; drug analysis in biological matrices; and pharmaco-genomic aspects related to drug disposition.
No pre-requisites or restrictions